Mon, November 16, 2020
Fri, November 13, 2020
Thu, November 12, 2020

David Lebovitz Maintained (ASND) at Buy with Increased Target to $199 on, Nov 13th, 2020

David Lebovitz of Morgan Stanley, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $194 to $199 on, Nov 13th, 2020.

David has made no other calls on ASND in the last 4 months.



There are 2 other peers that have a rating on ASND. Out of the 2 peers that are also analyzing ASND, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David


  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $191 on, Thursday, November 12th, 2020
  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Increased Target to $178 on, Thursday, November 12th, 2020